{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-07T10:05:10.387456+00:00","company":{"ticker":"AVNS","cik":1606498,"company_name":"AVANOS MEDICAL, INC."},"pagination":{"limit":100,"returned":20,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"295be4d8ae70b30b8c86ba7c744a7b161585d13f","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2026-05-05T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the three months ended March 31, 2026","report_date":"2026-05-05","result_type":"reported_results","revenue_text":null},"claim":"AVANOS MEDICAL, INC. reported financial results for the three months ended March 31, 2026.","evidence_excerpt":"On May 5, 2026, Avanos Medical, Inc. issued a press release announcing its results of operations for the three months ended March 31, 2026.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001606498-26-000061","anchor_url":"https://secwatch.observer/filing/0001606498-26-000061#claim-295be4d8ae70b30b8c86ba7c744a7b161585d13f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000061/0001606498-26-000061-index.htm"},{"fact_type":"material_agreement","fact_key":"58e620a84a34a54440be3f0346375d1b71b6eb58","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2026-04-14T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Agreement and Plan of Merger","agreement_type":"merger","counterparty":"A-AV Holdco I, Inc. and A-AV MergerSub, Inc.","effective_date":"2026-04-13","item_codes_triggered":["1.01"],"value_text":"$25.00 per Share in cash"},"claim":"AVANOS MEDICAL, INC. entered into Agreement and Plan of Merger with A-AV Holdco I, Inc. and A-AV MergerSub, Inc. valued at $25.00 per Share in cash (effective 2026-04-13).","evidence_excerpt":"On April 13, 2026, Avanos Medical, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, A-AV Holdco I, Inc., a Delaware corporation (“Parent”), and A-AV MergerSub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Subsidiary”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001606498-26-000046","anchor_url":"https://secwatch.observer/filing/0001606498-26-000046#claim-58e620a84a34a54440be3f0346375d1b71b6eb58","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000046/0001606498-26-000046-index.htm"},{"fact_type":"executive_change","fact_key":"737f70593b","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2025-04-30T23:59:59+00:00","payload":{"action":"departed","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":null,"role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Michael C. Greiner departed as other_named_officer at AVANOS MEDICAL, INC..","evidence_excerpt":"On April 28, 2025, Avanos Medical, Inc. (the “Company”) and Michael C. Greiner entered into a Separation and Consulting Agreement (the “Separation and Consulting Agreement”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-25-000085","anchor_url":"https://secwatch.observer/filing/0001606498-25-000085#claim-737f70593b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649825000085/0001606498-25-000085-index.htm"},{"fact_type":"executive_change","fact_key":"080428b0ef","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2025-04-28T23:59:59+00:00","payload":{"action":"no longer serves","action_category":"departure","departure_tone":"routine","effective_date":"2025-04-14","interim":true,"role":"Interim Chief Financial Officer","role_category":"cfo","successor_name":"Jason M. Pickett","successor_named":true},"claim":"Warren J. Machan departed as Interim Chief Financial Officer at AVANOS MEDICAL, INC..","evidence_excerpt":"Mr. Machan no longer serves as the Company’s Interim Chief Financial Officer effective April 14, 2025","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-25-000081","anchor_url":"https://secwatch.observer/filing/0001606498-25-000081#claim-080428b0ef","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649825000081/0001606498-25-000081-index.htm"},{"fact_type":"executive_change","fact_key":"4a37045a35","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2025-04-28T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-04-14","interim":true,"role":"Interim Chief Financial Officer and Treasurer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Jason M. Pickett was appointed as Interim Chief Financial Officer and Treasurer at AVANOS MEDICAL, INC..","evidence_excerpt":"The Company has appointed Jason M. Pickett as Interim Chief Financial Officer and Treasurer, effective April 14, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-25-000081","anchor_url":"https://secwatch.observer/filing/0001606498-25-000081#claim-4a37045a35","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649825000081/0001606498-25-000081-index.htm"},{"fact_type":"executive_change","fact_key":"413c0234a4","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2025-04-28T23:59:59+00:00","payload":{"action":"announced that he will leave","action_category":"departure","departure_tone":"termination","effective_date":"2025-04-18","interim":false,"role":"Senior Vice President, Chief Financial Officer and Chief Transformation Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Michael C. Greiner departed as Senior Vice President, Chief Financial Officer and Chief Transformation Officer at AVANOS MEDICAL, INC..","evidence_excerpt":"On April 18, 2025, Michael C. Greiner announced that he will leave the Company to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-25-000081","anchor_url":"https://secwatch.observer/filing/0001606498-25-000081#claim-413c0234a4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649825000081/0001606498-25-000081-index.htm"},{"fact_type":"executive_change","fact_key":"6b2a2c2dd7","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2025-04-18T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-04-14","interim":true,"role":"Interim Chief Financial Officer and Treasurer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Jason M. Pickett was appointed as Interim Chief Financial Officer and Treasurer at AVANOS MEDICAL, INC..","evidence_excerpt":"The Company has appointed Jason M. Pickett as Interim Chief Financial Officer and Treasurer, effective April 14, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-25-000064","anchor_url":"https://secwatch.observer/filing/0001606498-25-000064#claim-6b2a2c2dd7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649825000064/0001606498-25-000064-index.htm"},{"fact_type":"executive_change","fact_key":"53b219c98c","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2025-04-18T23:59:59+00:00","payload":{"action":"no longer serves","action_category":"departure","departure_tone":"routine","effective_date":"2025-04-14","interim":true,"role":"Interim Chief Financial Officer","role_category":"cfo","successor_name":"Jason M. Pickett","successor_named":true},"claim":"Warren J. Machan departed as Interim Chief Financial Officer at AVANOS MEDICAL, INC..","evidence_excerpt":"Mr. Machan no longer serves as the Company’s Interim Chief Financial Officer effective April 14, 2025","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-25-000064","anchor_url":"https://secwatch.observer/filing/0001606498-25-000064#claim-53b219c98c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649825000064/0001606498-25-000064-index.htm"},{"fact_type":"executive_change","fact_key":"bcb857d923","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2025-04-18T23:59:59+00:00","payload":{"action":"leave","action_category":"departure","departure_tone":"routine","effective_date":"2025-04-18","interim":false,"role":"Senior Vice President and Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Michael C. Greiner departed as Senior Vice President and Chief Financial Officer at AVANOS MEDICAL, INC..","evidence_excerpt":"On April 18, 2025, Michael C. Greiner announced that he will leave Avanos Medical, Inc. (the “Company”) to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-25-000064","anchor_url":"https://secwatch.observer/filing/0001606498-25-000064#claim-bcb857d923","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649825000064/0001606498-25-000064-index.htm"},{"fact_type":"executive_change","fact_key":"153fbaa047","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2025-04-18T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-04-14","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"David Pacitti was appointed as Chief Executive Officer at AVANOS MEDICAL, INC..","evidence_excerpt":"On March 17, 2025, Avanos Medical, Inc. (the “Company”) announced the appointment of David Pacitti as the Company’s Chief Executive Officer, effective April 14, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-25-000063","anchor_url":"https://secwatch.observer/filing/0001606498-25-000063#claim-153fbaa047","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649825000063/0001606498-25-000063-index.htm"},{"fact_type":"executive_change","fact_key":"7ea945779c","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2025-03-17T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-04-14","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"David Pacitti was appointed as Chief Executive Officer at AVANOS MEDICAL, INC..","evidence_excerpt":"On March 17, 2025, Avanos Medical, Inc. (the “Company”) announced the appointment of David Pacitti as the Company’s Chief Executive Officer, effective April 14, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-25-000057","anchor_url":"https://secwatch.observer/filing/0001606498-25-000057#claim-7ea945779c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649825000057/0001606498-25-000057-index.htm"},{"fact_type":"executive_change","fact_key":"19ea5d313c","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2024-10-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-10-28","interim":true,"role":"Interim Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Michael C. Greiner was appointed as Interim Chief Executive Officer at AVANOS MEDICAL, INC..","evidence_excerpt":"the Company appointed Michael C. Greiner to serve as Interim Chief Executive Officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-24-000082","anchor_url":"https://secwatch.observer/filing/0001606498-24-000082#claim-19ea5d313c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/0001606498-24-000082-index.htm"},{"fact_type":"executive_change","fact_key":"f9a1db72a2","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2024-10-30T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":"2024-10-28","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"Michael C. Greiner","successor_named":true},"claim":"Joseph F. Woody retired as Chief Executive Officer at AVANOS MEDICAL, INC..","evidence_excerpt":"On October 28, 2024, the Company announced the retirement of Joseph F. Woody as Chief Executive Officer and a member of the Board of Directors of the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-24-000082","anchor_url":"https://secwatch.observer/filing/0001606498-24-000082#claim-f9a1db72a2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/0001606498-24-000082-index.htm"},{"fact_type":"executive_change","fact_key":"51f4f406d4","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2024-07-01T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Indrani Franchini was appointed as Director at AVANOS MEDICAL, INC..","evidence_excerpt":"On June 28, 2024, the Board of Directors (the “Board”) of Avanos Medical, Inc. (the “Company”) appointed Indrani Franchini to the Board, effective July 1, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-24-000069","anchor_url":"https://secwatch.observer/filing/0001606498-24-000069#claim-51f4f406d4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000069/0001606498-24-000069-index.htm"},{"fact_type":"earnings_release","fact_key":"2ce7f4291e469a775befab04053df1af77e376cc","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2024-05-02T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"three months ended March 31, 2024","report_date":"2024-05-02","result_type":"reported_results","revenue_text":null},"claim":"AVANOS MEDICAL, INC. reported financial results for three months ended March 31, 2024.","evidence_excerpt":"On May 2, 2024, Avanos Medical, Inc. (the \"Company\") issued a press release announcing its results of operations for the three months ended March 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-24-000055","anchor_url":"https://secwatch.observer/filing/0001606498-24-000055#claim-2ce7f4291e469a775befab04053df1af77e376cc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000055/0001606498-24-000055-index.htm"},{"fact_type":"shareholder_vote","fact_key":"872b07553edf80610dc1f4501c4b26edb44e3f46","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2024-04-29T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-04-25","outcome":"passed","proposal_text":"To approve, on an advisory basis, the compensation of the Company’s named executive officers","proposal_type":"say_on_pay","results":[{"broker_non_votes":"2,312,795","subject":null,"votes_abstain":"57,555","votes_against":"2,104,432","votes_for":"38,515,084","votes_withheld":null}]},"claim":"AVANOS MEDICAL, INC. shareholders approved To approve, on an advisory basis, the compensation of the Company’s named executive officers at the 2024-04-25 meeting.","evidence_excerpt":"The votes cast on Proposal No. 3 were as follows: For Against Abstain Broker non-votes Approval of NEO compensation 38,515,084 2,104,432 57,555 2,312,795","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001606498-24-000053","anchor_url":"https://secwatch.observer/filing/0001606498-24-000053#claim-872b07553edf80610dc1f4501c4b26edb44e3f46","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000053/0001606498-24-000053-index.htm"},{"fact_type":"shareholder_vote","fact_key":"cb6c6c4652252921111a37b82b937653bc0f136f","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2024-04-29T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-04-25","outcome":"passed","proposal_text":"To ratify the appointment of Deloitte & Touche LLP as the Company’s independent auditors for 2024","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"50,285","votes_against":"435,813","votes_for":"42,503,768","votes_withheld":null}]},"claim":"AVANOS MEDICAL, INC. shareholders approved To ratify the appointment of Deloitte & Touche LLP as the Company’s independent auditors for 2024 at the 2024-04-25 meeting.","evidence_excerpt":"The votes cast on Proposal No. 2 were as follows: For Against Abstain Appointment of Deloitte & Touche LLP 42,503,768 435,813 50,285","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001606498-24-000053","anchor_url":"https://secwatch.observer/filing/0001606498-24-000053#claim-cb6c6c4652252921111a37b82b937653bc0f136f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000053/0001606498-24-000053-index.htm"},{"fact_type":"shareholder_vote","fact_key":"8cefa205665e81e12db60be74e70dff9de351cee","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2024-04-29T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-04-25","outcome":"passed","proposal_text":"To elect Gary D. Blackford, Dr. Lisa Egbuonu-Davis, Patrick J. O’Leary, Dr. Julie Shimer and Joseph F. Woody to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders","proposal_type":"director_election","results":[{"broker_non_votes":"2,312,795","subject":"Gary D. Blackford","votes_abstain":null,"votes_against":null,"votes_for":"39,916,596","votes_withheld":"760,475"},{"broker_non_votes":"2,312,795","subject":"Dr. Lisa Egbuonu-Davis","votes_abstain":null,"votes_against":null,"votes_for":"39,845,016","votes_withheld":"832,055"},{"broker_non_votes":"2,312,795","subject":"Patrick J. O’Leary","votes_abstain":null,"votes_against":null,"votes_for":"40,149,326","votes_withheld":"527,745"},{"broker_non_votes":"2,312,795","subject":"Dr. Julie Shimer","votes_abstain":null,"votes_against":null,"votes_for":"39,726,238","votes_withheld":"950,833"},{"broker_non_votes":"2,312,795","subject":"Joseph F. Woody","votes_abstain":null,"votes_against":null,"votes_for":"40,385,119","votes_withheld":"291,952"}]},"claim":"AVANOS MEDICAL, INC. shareholders approved To elect Gary D. Blackford, Dr. Lisa Egbuonu-Davis, Patrick J. O’Leary, Dr. Julie Shimer and Joseph F. Woody to serve one-year terms expiring at the 2025 Annual Meeting of Stockholders at the 2024-04-25 meeting.","evidence_excerpt":"The votes cast on Proposal No. 1 were as follows: Director For Withhold Broker non-votes Gary D. Blackford 39,916,596 760,475 2,312,795 Dr. Lisa Egbuonu-Davis 39,845,016 832,055 2,312,795 Patrick J. O’Leary 40,149,326 527,745 2,312,795 Dr. Julie Shimer 39,726,238 950,833 2,312,795 Joseph F. Woody 40,385,119 291,952 2,312,795","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001606498-24-000053","anchor_url":"https://secwatch.observer/filing/0001606498-24-000053#claim-8cefa205665e81e12db60be74e70dff9de351cee","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000053/0001606498-24-000053-index.htm"},{"fact_type":"earnings_release","fact_key":"b3eb95efd3a463afc3ba136e78079316a61824a3","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2024-02-20T23:59:59+00:00","payload":{"eps_text":"Fourth quarter diluted earnings per share from continuing operations were $0.24 compared to diluted earnings per share o","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"fourth quarter and full-year 2023","report_date":"2024-02-20","result_type":"reported_results","revenue_text":"Fourth quarter net sales from continuing operations totaled $173.3 million, a 4.6% decrease from the prior year. For the"},"claim":"AVANOS MEDICAL, INC. reported fourth quarter and full-year 2023 results: revenue Fourth quarter net sales from continuing operations totaled $173.3 million, a 4.6% decrease from the prior year. For the, EPS Fourth quarter diluted earnings per share from continuing operations were $0.24 compared to diluted earnings per share o.","evidence_excerpt":"Fourth quarter net sales from continuing operations totaled $173.3 million, a 4.6% decrease from the prior year. For the full-year, net sales from continuing operations decreased 1.6% to $673.3 million. • Fourth quarter diluted earnings per share from continuing operations were $0.24 compared to diluted earnings per share of $0.21 per share a year ago, and fourth quarter adjusted diluted earnings per share from continuing operations were $0.36 compared to $0.45 in the prior year. 2023 full-year diluted loss per share from continuing operations were $0.21 compared to diluted earnings per share of $0.46 in the prior year, and adjusted diluted earnings per share from continuing operations were $1.03 compared to $1.00 in 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001606498-24-000016","anchor_url":"https://secwatch.observer/filing/0001606498-24-000016#claim-b3eb95efd3a463afc3ba136e78079316a61824a3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000016/0001606498-24-000016-index.htm"},{"fact_type":"earnings_release","fact_key":"25b26b59b7868d909e4dd229e458a25b4e34951b","cik":1606498,"ticker":"AVNS","company_name":"AVANOS MEDICAL, INC.","filed_at":"2024-01-04T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the quarter and full-year ended December 31, 2023","report_date":"2024-01-04","result_type":"preliminary_results","revenue_text":null},"claim":"AVANOS MEDICAL, INC. reported preliminary financial results for the quarter and full-year ended December 31, 2023.","evidence_excerpt":"On January 4, 2024, Avanos Medical, Inc. (the “Company”) issued a press release that announced selected, unaudited preliminary financial results for the quarter and full-year ended December 31, 2023.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001606498-24-000002","anchor_url":"https://secwatch.observer/filing/0001606498-24-000002#claim-25b26b59b7868d909e4dd229e458a25b4e34951b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000002/0001606498-24-000002-index.htm"}]}